Johnson & Johnson

Janssen Pharmaceutica

‘Caring for the world, one person at a time’… inspires and unites the people of Johnson & Johnson. We embrace research and science – bringing innovative ideas, products and services to advance the health and well-being of people.
Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.
Janssen Pharmaceutica joined the Johnson & Johnson group in 1961. Today, Janssen Pharmaceutica is one of the most innovative pharmaceutical companies in the world.
Janssen Research & Development
Worldwide, Janssen R&D focuses on five domains: neuroscience, cardiovascular diseases and metabolism, infectious diseases, immunology and oncology. Within these areas, the focus is on the research and development of vaccines, small and large molecules. Our campus in Beerse, Belgium, is the largest R&D center within the entire Janssen group focusing in the discovery of small and large molecules.
It is the engine behind the continuous innovation at Janssen. In this campus, we invest over 1 billion euros each year in R&D!
Researchers and laboratory workers with different nationalities work together on a daily basis to improve and innovate. The know-how on our campus – one of the leading R&D centers in the Janssen group and beyond – is also continually growing.
We offer our (Senior) Scientists a platform to work with the best and most experience people in their scientific field.


Johnson & Johnson
Janssen Pharmaceutica
Turnhoutseweg 30
2340 Beerse
Field of Activity:
Clinical Research
Hospital & Medical Practice
Other Activities
Pharmacy & OTC
Research & Development
Number of employess:
more than 500